Takara Bio Inc.

Company

Also known as: Takara Bio

Related News

Related Clinical Trials

NCT ID Title Status Phase
NCT05963217

Study of TBI-2001(Autologous CD19 Specific Chimeric Antigen Receptor (CAR) Gene-transduced T Lymphocytes) for Relapsed or Refractory CD19+ B-cell Lymphoma, CLL/SLL

RECRUITING PHASE1